Immunopathobiology and therapeutic targets related to cytokines in liver diseases

Y He, S Hwang, YA Ahmed, D Feng, N Li… - Cellular & molecular …, 2021 - nature.com
Chronic liver injury with any etiology can progress to fibrosis and the end-stage diseases
cirrhosis and hepatocellular carcinoma. The progression of liver disease is controlled by a …
被引用次数：80 相关文章
[HTML] nih.gov

[HTML][HTML] Immunopathobiology and therapeutic targets related to cytokines in liver diseases

Y He, S Hwang, YA Ahmed, D Feng, N Li… - Cellular and …, 2021 - ncbi.nlm.nih.gov
Chronic liver injury with any etiology can progress to fibrosis and the end-stage diseases
cirrhosis and hepatocellular carcinoma. The progression of liver disease is controlled by a …

Immunopathobiology and therapeutic targets related to cytokines in liver diseases

Y He, S Hwang, YA Ahmed, D Feng… - Cellular & …, 2021 - pubmed.ncbi.nlm.nih.gov
Chronic liver injury with any etiology can progress to fibrosis and the end-stage diseases
cirrhosis and hepatocellular carcinoma. The progression of liver disease is controlled by a …

Immunopathobiology and therapeutic targets related to cytokines in liver diseases

Y He, H Seonghwan, AY Ait, F Dechun… - Cellular & …, 2021 - search.proquest.com
Chronic liver injury with any etiology can progress to fibrosis and the end-stage diseases
cirrhosis and hepatocellular carcinoma. The progression of liver disease is controlled by a …

Immunopathobiology and therapeutic targets related to cytokines in liver diseases.

Y He, S Hwang, YA Ahmed, D Feng, N Li… - Cellular & Molecular …, 2020 - europepmc.org
Chronic liver injury with any etiology can progress to fibrosis and the end-stage diseases
cirrhosis and hepatocellular carcinoma. The progression of liver disease is controlled by a …